간 이식 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently published an extensive report on the global Liver Transplantation Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Liver Transplantation Market Size (2025E): USD 1901 Mn
• Projected Market Value (2032F): USD 3010.1 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 6.8%

Liver Transplantation Market - Report Scope:

The Liver Transplantation Market encompasses a range of procedures, technologies, and donor sources for liver transplants, primarily used to treat severe liver diseases, including cirrhosis, hepatocellular carcinoma, and acute liver failure. The market involves both cadaveric and living donor transplantation techniques, with advancements in surgical procedures, immunosuppressive drugs, and post-operative care driving growth. The increasing prevalence of liver diseases, coupled with the growing acceptance of organ donation, is fueling market expansion.

Market Growth Drivers:

Several key factors are driving the global Liver Transplantation Market. The rising incidence of liver diseases due to alcohol consumption, viral hepatitis, and non-alcoholic fatty liver disease (NAFLD) has significantly increased the demand for liver transplants. Moreover, advancements in surgical techniques, including minimally invasive transplantation and robotic-assisted surgeries, have improved success rates and patient outcomes. The development of new immunosuppressive drugs has also reduced the risk of organ rejection, further supporting market growth. Additionally, government initiatives and awareness programs promoting organ donation and transplantation infrastructure development are expected to boost market expansion.

Market Restraints:

Despite promising growth prospects, the Liver Transplantation Market faces several challenges. The high cost of liver transplantation, including pre-operative, surgical, and post-operative expenses, remains a significant barrier, particularly in developing countries. The limited availability of donor organs further restricts market growth, leading to long waiting lists and increased mortality rates among patients in need. Additionally, post-transplant complications such as infections, organ rejection, and side effects of immunosuppressive therapy pose challenges to successful transplant outcomes. Stringent regulatory requirements and ethical concerns regarding organ procurement also impact market expansion.

Market Opportunities:

The market presents significant opportunities driven by technological advancements in organ preservation and transplant techniques. The introduction of machine perfusion technology, which enhances the viability of donor livers and extends preservation time, is expected to improve transplant success rates. The increasing adoption of bioengineering and regenerative medicine, including 3D-printed liver tissues and stem cell therapy, offers promising alternatives to traditional transplantation. Furthermore, growing investments in transplant centers, collaborations between healthcare organizations, and initiatives promoting living donor programs provide new growth avenues. Expanding healthcare access in emerging economies and favorable reimbursement policies also contribute to market development.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Liver Transplantation Market globally?
• How are technological advancements influencing the competitive landscape of the Liver Transplantation Market?
• What are the major challenges faced by liver transplant patients and healthcare providers?
• Who are the key players in the Liver Transplantation Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Liver Transplantation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Liver Transplantation Market, including healthcare institutions, pharmaceutical companies, and medical device manufacturers, focus on research and development to improve transplant success rates and patient outcomes. Companies invest in developing advanced organ preservation solutions, artificial liver support devices, and improved immunosuppressants to address transplant-related challenges. Collaborations between transplant centers and biotechnology firms are facilitating new treatment modalities, such as xenotransplantation and bioengineered livers. Additionally, initiatives aimed at increasing organ donation rates and improving accessibility to transplantation services are being implemented to drive market growth.

Key Companies Profiled:

• Allosource
• Conatus Pharmaceuticals Inc.
• Digna Biotech S.L.
• Dompe Farmaceutici S.p.A.
• Isogenis, Inc.
• RedHill Biopharma Ltd.
• Thompson Surgical
• Integra Life Sciences
• Baxter International Inc.
• XVIVO
• VirTech Bio

Liver Transplantation Market Research Segmentation

By Product Type:

• Organ Preservation Solutions
• Immunosuppressive Drugs
• Others

By Treatment Type:

• Liver Transplantation Surgery
• Post-Surgery Anti-Rejection Treatment
• Cyclosporine
• Tacrolimus
• Sirolimus Prednisone Azathioprine
• Mycophenolate Mofetil

By End-use:

• Hospitals
• Adult Liver Transplantation Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Liver Transplantation Market Snapshot, 2025 - 2032
• 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Product Type Lifecycle Analysis
• 2.4. Liver Transplantation Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019 - 2023
  • 3.2.2. Current Market Size Forecast, 2025 - 2032
• 3.3. Global Liver Transplantation Market Outlook: Product Type
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019 - 2023
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 3.3.3.1. Organ Preservation Solutions
    • 3.3.3.2. Immunosuppressive Drugs
    • 3.3.3.3. Others
• 3.4. Market Attractiveness Analysis: Product Type
• 3.5. Global Liver Transplantation Market Outlook: Treatment Type
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2019 - 2023
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 3.5.3.1. Liver Transplantation Surgery
    • 3.5.3.2. Post-Surgery Anti-Rejection Treatment
    • 3.5.3.3. Cyclosporine
    • 3.5.3.4. Tacrolimus
    • 3.5.3.5. Sirolimus Prednisone Azathioprine
    • 3.5.3.6. Mycophenolate Mofetil
• 3.6. Market Attractiveness Analysis: Treatment Type
• 3.7. Global Liver Transplantation Market Outlook: End-use
  • 3.7.1. Introduction / Key Findings
  • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-use, 2019 - 2023
  • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 3.7.3.1. Hospitals
    • 3.7.3.2. Adult liver transplantation centers
    • 3.7.3.3. Ambulatory surgical centers
• 3.8. Market Attractiveness Analysis: End-use

4. Global Liver Transplantation Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia & Pacific
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 5.3.1. By Country
  • 5.3.2. By Product Type
  • 5.3.3. By Treatment Type
  • 5.3.4. By End-use
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 5.5.1. Organ Preservation Solutions
  • 5.5.2. Immunosuppressive Drugs
  • 5.5.3. Others
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 5.6.1. Liver Transplantation Surgery
  • 5.6.2. Post-Surgery Anti-Rejection Treatment
  • 5.6.3. Cyclosporine
  • 5.6.4. Tacrolimus
  • 5.6.5. Sirolimus Prednisone Azathioprine
  • 5.6.6. Mycophenolate Mofetil
• 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 5.7.1. Hospitals
  • 5.7.2. Adult liver transplantation centers
  • 5.7.3. Ambulatory surgical centers
• 5.8. Market Attractiveness Analysis

6. Europe Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 6.3.1. By Country
  • 6.3.2. By Product Type
  • 6.3.3. By Treatment Type
  • 6.3.4. By End-use
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkey
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 6.5.1. Organ Preservation Solutions
  • 6.5.2. Immunosuppressive Drugs
  • 6.5.3. Others
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 6.6.1. Liver Transplantation Surgery
  • 6.6.2. Post-Surgery Anti-Rejection Treatment
  • 6.6.3. Cyclosporine
  • 6.6.4. Tacrolimus
  • 6.6.5. Sirolimus Prednisone Azathioprine
  • 6.6.6. Mycophenolate Mofetil
• 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 6.7.1. Hospitals
  • 6.7.2. Adult liver transplantation centers
  • 6.7.3. Ambulatory surgical centers
• 6.8. Market Attractiveness Analysis

7. East Asia Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 7.3.1. By Country
  • 7.3.2. By Product Type
  • 7.3.3. By Treatment Type
  • 7.3.4. By End-use
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 7.5.1. Organ Preservation Solutions
  • 7.5.2. Immunosuppressive Drugs
  • 7.5.3. Others
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 7.6.1. Liver Transplantation Surgery
  • 7.6.2. Post-Surgery Anti-Rejection Treatment
  • 7.6.3. Cyclosporine
  • 7.6.4. Tacrolimus
  • 7.6.5. Sirolimus Prednisone Azathioprine
  • 7.6.6. Mycophenolate Mofetil
• 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 7.7.1. Hospitals
  • 7.7.2. Adult liver transplantation centers
  • 7.7.3. Ambulatory surgical centers
• 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 8.3.1. By Country
  • 8.3.2. By Product Type
  • 8.3.3. By Treatment Type
  • 8.3.4. By End-use
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 8.5.1. Organ Preservation Solutions
  • 8.5.2. Immunosuppressive Drugs
  • 8.5.3. Others
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 8.6.1. Liver Transplantation Surgery
  • 8.6.2. Post-Surgery Anti-Rejection Treatment
  • 8.6.3. Cyclosporine
  • 8.6.4. Tacrolimus
  • 8.6.5. Sirolimus Prednisone Azathioprine
  • 8.6.6. Mycophenolate Mofetil
• 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 8.7.1. Hospitals
  • 8.7.2. Adult liver transplantation centers
  • 8.7.3. Ambulatory surgical centers
• 8.8. Market Attractiveness Analysis

9. Latin America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 9.3.1. By Country
  • 9.3.2. By Product Type
  • 9.3.3. By Treatment Type
  • 9.3.4. By End-use
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 9.5.1. Organ Preservation Solutions
  • 9.5.2. Immunosuppressive Drugs
  • 9.5.3. Others
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 9.6.1. Liver Transplantation Surgery
  • 9.6.2. Post-Surgery Anti-Rejection Treatment
  • 9.6.3. Cyclosporine
  • 9.6.4. Tacrolimus
  • 9.6.5. Sirolimus Prednisone Azathioprine
  • 9.6.6. Mycophenolate Mofetil
• 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 9.7.1. Hospitals
  • 9.7.2. Adult liver transplantation centers
  • 9.7.3. Ambulatory surgical centers
• 9.8. Market Attractiveness Analysis

10. Middle East & Africa Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By Treatment Type
  • 10.3.4. By End-use
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
  • 10.5.1. Organ Preservation Solutions
  • 10.5.2. Immunosuppressive Drugs
  • 10.5.3. Others
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
  • 10.6.1. Liver Transplantation Surgery
  • 10.6.2. Post-Surgery Anti-Rejection Treatment
  • 10.6.3. Cyclosporine
  • 10.6.4. Tacrolimus
  • 10.6.5. Sirolimus Prednisone Azathioprine
  • 10.6.6. Mycophenolate Mofetil
• 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
  • 10.7.1. Hospitals
  • 10.7.2. Adult liver transplantation centers
  • 10.7.3. Ambulatory surgical centers
• 10.8. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2024
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Immunosuppressive Drugs
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Allosource
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Conatus Pharmaceuticals Inc.
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Digna Biotech S.L.
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Dompe Farmaceutici S.p.A.
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Isogenis, Inc.
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. RedHill Biopharma Ltd.
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Product
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Thompson Surgical
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Product
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. Integra Life Sciences
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Product
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. Baxter International Inc.
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Product
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. XVIVO
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Product
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy
  • 11.3.11. VirTech Bio
    • 11.3.11.1. Overview
    • 11.3.11.2. Segments and Product
    • 11.3.11.3. Key Financials
    • 11.3.11.4. Market Developments
    • 11.3.11.5. Market Strategy
  • 11.3.12. Vital Therapies
    • 11.3.12.1. Overview
    • 11.3.12.2. Segments and Product
    • 11.3.12.3. Key Financials
    • 11.3.12.4. Market Developments
    • 11.3.12.5. Market Strategy
  • 11.3.13. HepaTx
    • 11.3.13.1. Overview
    • 11.3.13.2. Segments and Product
    • 11.3.13.3. Key Financials
    • 11.3.13.4. Market Developments
    • 11.3.13.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations